BEGIN:VCALENDAR
VERSION:2.0
PRODID:IEEE vTools.Events//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:Canada/Eastern
BEGIN:DAYLIGHT
DTSTART:20220313T030000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:EDT
END:DAYLIGHT
BEGIN:STANDARD
DTSTART:20211107T010000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:EST
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20211119T004008Z
UID:B8F8560A-CAB6-405E-B76F-253D902FF9DF
DTSTART;TZID=Canada/Eastern:20211108T113000
DTEND;TZID=Canada/Eastern:20211108T123000
DESCRIPTION:Nanomedicine\, nanotechnology applications in medicine\, is a m
 ultidisciplinary research field that integrates principles from chemistry\
 , biology\, physics\, engineering\, and nanotechnology to develop diagnost
 ic tools and therapeutics to improve human health. Nanomedicines focus on 
 improving pharmacokinetics\, achieving a higher accumulation of drugs at t
 he disease site\, and target-specific delivery at cellular and subcellular
  levels. In this presentation\, nanomedicines development\; and their ther
 apeutic potential in cancer and cardiovascular diseases will be discussed.
  In addition\, nanotechnology-based tools to study the fundamentals of nan
 o-bio interactions at the cellular and tissue level will also be addressed
 .\n\nSpeaker(s): Dr. Suresh Gadde\, \n\nVirtual: https://events.vtools.iee
 e.org/m/288756
LOCATION:Virtual: https://events.vtools.ieee.org/m/288756
ORGANIZER:sreeramanr@sce.carleton.ca
SEQUENCE:2
SUMMARY:Nanotechnology-based therapeutic approaches in healthcare applicati
 ons
URL;VALUE=URI:https://events.vtools.ieee.org/m/288756
X-ALT-DESC:Description: &lt;br /&gt;&lt;p&gt;Nanomedicine\, nanotechnology applications
  in medicine\, is a multidisciplinary research field that integrates princ
 iples from chemistry\, biology\, physics\, engineering\, and nanotechnolog
 y to develop diagnostic tools and therapeutics to improve human health. Na
 nomedicines focus on improving pharmacokinetics\, achieving a higher accum
 ulation of drugs at the disease site\, and target-specific delivery at cel
 lular and subcellular levels. In this presentation\, nanomedicines develop
 ment\; and their therapeutic potential in cancer and cardiovascular diseas
 es will be discussed. In addition\, nanotechnology-based tools to study th
 e fundamentals of nano-bio interactions at the cellular and tissue level w
 ill also be addressed.&lt;/p&gt;
END:VEVENT
END:VCALENDAR

